Moderna Reports Success in Personalized Melanoma Vaccine; Potential Availability Next Year

Moderna announced successful testing of a personalized melanoma vaccine, with potential availability as early as next year. The vaccine's mechanism may extend to other cancer types, though efficacy data and regulatory approval remain pending. This marks a significant step in personalized cancer immunotherapy.